The TZ-PD trial will be a 1:1 (active:placebo) randomized, double-blind, placebo-controlled
Phase II trial to evaluate the safety and tolerability of terazosin for the treatment of PD.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Jordan Schultz
Collaborators:
University of Iowa University of Iowa Institute of Clinical and Translational Sciences